Cassel Research Laboratories Profile
Key Indicators
- Authorised Capital ₹ 4.00 Cr
- Paid Up Capital ₹ 3.75 Cr
- Company Age 26 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 11.90 Cr
- Revenue Growth 6.05%
- Profit Growth -59.04%
- Ebitda -1775.32%
- Net Worth -46.07%
- Total Assets -21.29%
About Cassel Research Laboratories
Cassel Research Laboratories Private Limited (CRLPL) is a Private Limited Indian Non-Government Company incorporated in India on 21 December 1998 and has a history of 26 years and two months. Its registered office is in Chennai, Tamil Nadu, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.00 Cr and a paid-up capital of Rs 3.75 Cr.
The company has closed loans amounting to ₹11.90 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Lakshmanan Rajamani, Nehrudassan Rajamani, Murugan Sean, and One other member serve as directors at the Company.
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24231TN1998PTC041617
- Company No.
041617
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Dec 1998
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Cassel Research Laboratories?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Lakshmanan Rajamani  | Director | 21-Dec-1998 | Current |
| Nehrudassan Rajamani | Director | 21-Dec-1998 | Current |
| Murugan Sean | Director | 22-Mar-2022 | Current |
| Vengatesan Manian | Director | 21-Dec-1998 | Current |
Financial Performance of Cassel Research Laboratories.
Cassel Research Laboratories Private Limited, for the financial year ended 2017, experienced modest growth in revenue, with a 6.05% increase. The company also saw a substantial fall in profitability, with a 59.04% decrease in profit. The company's net worth observed a substantial decline by a decrease of 46.07%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cassel Research Laboratories?
In 2017, Cassel Research Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Lessac Research Laboratories Private Limited
Lakshmanan Rajamani and Murugan Sean are mutual person
- Madras Printers Private Limited
Murugan Sean is a mutual person
Charges (Loans)
₹0
₹11.90 Cr
Charges Breakdown by Lending Institutions
- Indian Overseas Bank : 11.90 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 19 Jun 2004 | Indian Overseas Bank | ₹11.90 Cr | Satisfied |
How Many Employees Work at Cassel Research Laboratories?
Unlock and access historical data on people associated with Cassel Research Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cassel Research Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cassel Research Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
